Position Paper on IPT Action
(updated December 18, 2000)
Insulin potentiation therapy (IPT)
has been around for a long time without being known, without being researched
and tested, without being used for the benefit of large numbers of patients for
treatment of many diseases. If IPT is real, if it works, if it could be of
great value to millions of patients, then there can be no good excuse for this
blocked state of affairs.
My goal in publishing IPTQ.org is
to help turn this situation around by dissolving many of the hurdles
that have stood in the way of IPT for 72 years.
The primary function of IPTQ.org
is to make information about IPT quickly and easily available to anyone with a
web browser. Technical and non-technical information about IPT is now
available here, worldwide, for the first time ever. Before IPTQ, we would
have to talk to people individually, and get them more information by
photocopies and fax. This is no longer the case. People can view and
print IPT information as they wish. And now anyone can share this library
of information with anyone else by sending them an
email about IPT, with the web address http://www.iptq.org
. This sets the stage for rapid growth of IPT recognition through
recommendation by friends and associates.
A secondary function of IPTQ.org
is to advocate for IPT-related action. Without individual and collective
action, another 72 years could go by without the benefits of IPT being available
to mankind. The
actions we favor include:
- Education of the public about IPT. People need to know that
IPT exists now, that it has been around (but not on a large scale) for seven
decades, that it is being researched, and that more doctors are learning and
applying it today. Public awareness, interest, and demand will speed
research and deployment of IPT.
- Education of doctors about IPT. If IPT works, it could answer
the dreams of doctors for a way to treat diseases faster, more effectively,
at lower cost, and with better outcomes for their patients. Training
in IPT is simple and fast. As more doctors become interested in IPT,
learn and apply the IPT method, report their results, and share information,
IPT will enter the mainstream of medicine.
- More IPT research. Clinical trials will show us whether
or not the glowing anecdotal reports from 130 plus doctor-years of IPT practice
can be corroborated and extended in a wider clinical setting.
Laboratory research will help us understand better what is going on during
IPT, and why it apparently works so well.
- Invite Dr. Perez Garcia to move to the US. Here he
can be most effective in teaching and consulting with doctors, ensuring that
IPT treatment programs are well designed, and helping define the research
agenda. This would make it so much easier for everyone to take
advantage of the 104 years of cumulative IPT experience in his family, that
he represents. As he puts it, to have a really good French restaurant, you would
want the best French chef in the kitchen. Dr. Perez Garcia is
the master chef of IPT. San Francisco Bay Area is his first
choice of locations, but he is open to other possibilities.
- Education of governments and officials. These are the
people who can fund much of the research, and who can see that IPT is
applied once it has been clearly established to provide better results at
- Education of business people. Healthcare providers,
medical device manufacturers, and even pharmaceutical companies will
discover that widespread implementation of IPT could create many large
business opportunities, whether for new products or lowered costs.
- Implementation of IPT in the developing world, where
appropriate. A small amount of research should tell us if IPT could be
a better and practical treatment for some of the plagues of humanity, and if
it can perhaps help address the problems of drug resistance in disease
If IPT can speed treatment, have better results, and lower costs, even at
the expense of a little more complexity and a higher level of training for
health workers, then it will be a major
breakthrough for the world.
- Attracting philanthropists to IPT. IPT appears to promise a
huge multiplier of benefits relative to costs. A few million dollars
invested in IPT could provide trillions of dollars of value for humanity,
and could immeasurably help countless individual lives. I am looking
for the right person or people to lead the way.
In addition to publishing IPTQ.org
on the web, I have also proposed the establishment of the Stanford
IPT Research Initiative (SIPTRI) to help establish Stanford University (in
cooperation with the University of California at San Francisco) as a premiere
clinical and laboratory center for IPT research, training, and implementation.
The intellectual, financial, and technological resources here in the Bay Area
are unmatched anywhere. So this seems to be an ideal place to catalyze the
further evolution of IPT. I was turned down for funding by the Stanford Bio-X
Program, but am discussing possibilities with faculty members of the
Stanford Medical School and with private funding sources. Other
universities and cities are also being considered.
In conclusion, I am very
optimistic about the prospects for ending 70 years of inaction on IPT, quickly
and soon. And through IPTQ.org and other initiatives, I am looking forward to playing
a role in this evolution.
Sincerely, Chris Duffield Ph.D.,
webhost of IPTQ.org